US Pharma MarketingQuantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPO
Quantum firm hailed by Amgen tech leader as an ‘extraordinary platform’ plans IPO is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
A quantum tech firm that has collaborated with—and received investment from—Amgen is now planning to go public.
Source: FierceBiotech